Related Experiment Video
Updated: Nov 6, 2025

Author Spotlight: Investigating Wound Healing in Mice Models of Oronasal Fistulas
Published on: September 8, 2023
Rhinomaxillary mucormycosis presenting as palatal ulcer: A case report with comprehensive pathophysiology
Meenal Verma1, Rakhee Sharma1, Nikhil Verma2
1Department of Oral Pathology, Geetanjali Dental and Research Institute, Udaipur, Rajasthan, India.
Abstract:
Mucormycosis is an emerging fungal infection which has exceptionally high mortality rates in immunocompromised patients and remains a life-threatening infection in uncontrolled diabetics. The reported cases in literature may be less in number due to its frequent misdiagnosis. Imaging techniques in the early stages are usually nondiagnostic and cytological smears are not very reliable, thus, the gold standard for definitive diagnosis remains with the histopathological examination. A thorough understanding of the pathogenesis and host fungus interaction aids in the histopathological evaluation and clinical management. Despite of surgical and medical management, the overall mortality rate remains high in persistently immunocompromised individuals. We present a case report of a 58-year-old female patient with rhinomaxillary mucormycosis with a history of uncontrolled diabetes.
Insights
Mucormycosis is a dangerous fungal infection, especially in immunocompromised individuals and uncontrolled diabetics. Early diagnosis is challenging, making histopathology crucial for definitive identification and management.
Area of Science:
- Mycology
- Infectious Diseases
- Pathogenesis
Background:
- Mucormycosis presents a significant threat to immunocompromised patients, particularly those with uncontrolled diabetes.
- Accurate diagnosis is often delayed due to non-specific early imaging and unreliable cytological smears.
Observation:
- This case report details a 58-year-old female diagnosed with rhinomaxillary mucormycosis.
- The patient had a history of uncontrolled diabetes mellitus.
Findings:
- Histopathological examination remains the gold standard for definitive diagnosis of mucormycosis.
- Understanding host-fungus interactions is key for effective histopathological evaluation and treatment.
Implications:
- Despite current treatments, mortality rates for mucormycosis remain high in persistently immunocompromised individuals.
- Improved diagnostic strategies and a deeper understanding of pathogenesis are needed to improve patient outcomes.
Related Concept Videos
Fungal Group Zygomycota
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
